Skip to content

Intraoperative Sedation and Postoperative Delirium

Prevalence of Postoperative Delirium According to the Use of Dexmedetomidine or Propofol in Elderly Patients Undergoing Orthopedic Surgery: Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02573558
Enrollment
855
Registered
2015-10-12
Start date
2015-10-31
Completion date
2016-01-31
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedics

Brief summary

Delirium are common after orthopedic surgery in the elderly and are directly associated with loss of independence, reduction in the quality of life and increased mortality. The cause of postoperative delirium still remains unclear and may be multifactorial. The aim of this retrospective study is to examine prevalence of postoperative delirium according to the use of dexmedetomidine or propofol in elderly patients undergoing orthopedic surgery under regional anesthesia.

Interventions

DRUGDexmedetomidine
DRUGPropofol

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who underwent orthopedic surgery under regional anesthesia * age of 65 years or greater

Exclusion criteria

* General anesthesia * age \< 65 years * central nervous system disease, including dementia and Parkinson's disease * Patients who were not received sedation with propofol or dexmedetomidine during the operation

Design outcomes

Primary

MeasureTime frame
deliriumwithin 7 day postoperatively

Secondary

MeasureTime frame
Wound infectionwithin 7 day postoperatively
Pulmonary thromboembolismwithin 7 day postoperatively
Hospital staythrough study completion, an average of 7days

Other

MeasureTime frame
Renal failurewithin 7 day postoperatively
Hepatic failurewithin 7 day postoperatively
Myocardial ischemiawithin 7 day postoperatively

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026